Piper Sandler: 'Is now the time to buy STERIS (STE)?'

May 21, 2026 8:59 AM

Piper Sandler analyst Jason Bednar reiterated an Overweight rating and $270.00 price target on STERIS (NYSE: STE).The analyst commented: "Is ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found